Andhra Pradesh - Hyderabad   

Clinical trials of clot-busting drug launched

HYDERABAD: Bharat Biotech announced on Friday that it has initiated a Phase-III trial in the country with clot-busting drug THR-100 ( Staphylokinase) in patients suffering from acute myocardial infraction or heart attack. The trial is expected to recruit approximately 120 patients.

According to a press release here on Friday, Bharat Biotech entered into a license agreement with ThromboGenics for the manufacture, clinical development and commercialisation of THR-100 as a replacement for established thrombolytics such as streptokinase and urokinase in developing markets.

THR-100, a novel variant of recombinant Staphylokinase, is a thrombolytic agent developed by ThromboGenics for the treatment of acute myocardial infraction and other vascular diseases.

The Phase-III trial will be completed in the second half of this year and its results will pave the way for the company to file for marketing approval with Indian regulatory authorities.

Printer friendly page  
Send this article to Friends by E-Mail

Stories in this Section

15 per cent built up space for poor
Clinical trials of clot-busting drug launched
Jagan calls on family of deceased engg. student
Two new electrical inspectorate divisions created
‘Chiru entry will not alter Congress stand on Telangana'
Common recruitment to fill paramilitary posts in State
Spurious drug cases: States told to set up courts
‘YSR e-mail not fictitious'
Action plan finalised for power supply in summer
Irrigation sector facing 50 p.c. cut in funds
Unhindered view of Charminar to be a reality
Indians at higher risk of heart diseases, says expert
Issue of EPIC cards simplified
Cartoon carnival held at McDonalds
HMDA to auction 96 plots
Manmohan to inaugurate Commonwealth law meet
Health Department employees in ACB net
Police recover stolen jewellery, 15 held
“No differences over probe into girl's death”
Task force to monitor jails
Proposals to make RTC competitive announced
MP for bridges over rivers
Furniture designed for the aesthete
Attack on scribes: APUWJ to protest on February 14
Girl child issue: rise in primetime telecast
‘Develop character for bettering society'
Central team to assess crop damage
Special issue of ‘Ailaan' released
Naidu to visit Prakasam, Guntur to take up weavers cause
In Hyderabad Today

Copyright © 2011, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu